Creative Biolabs has unveiled a suite of advanced neuroscience platforms designed to support research into neurodegenerative diseases such as Alzheimer's disease, which affects millions worldwide. The World Health Organization reports that over 55 million people live with dementia globally, with Alzheimer's accounting for up to 70% of cases. To meet the growing demand for translational tools, the company has developed specialized platforms focusing on key cellular mechanisms in both the peripheral and central nervous systems.
One of the newly launched platforms targets Schwann cells, which are essential for axonal regeneration and myelination in the peripheral nervous system. The Schwann Cell Assay platform can isolate Schwann cells from human, mouse, and rat sources. It supports a co-culture system with neurons, enabling researchers to assess neurotrophic factor secretion and myelination potential—critical functions for regenerative medicine. This platform provides a robust tool for studying peripheral nerve injury and repair.
For central nervous system research, Creative Biolabs introduced a microglia phagocytosis assay service. Microglia, the brain's resident immune cells, play a key role in neuroinflammation and clearing pathological protein aggregates. The assay uses live-cell imaging and fluorescently labeled bioparticles to visualize phagocytic function in real time. Additionally, the company will host a webinar on September 18, 2025, at 10:00 AM EDT, focusing on the role of microglia in Alzheimer's disease. Interested parties can register in advance.
Creative Biolabs has also developed preclinical assessment services for Alzheimer's disease models, offering both 2D and 3D platforms that recapitulate key disease features such as amyloid deposition, tauopathy, and neuroinflammation. These models can be familial or sporadic, derived from patient-induced pluripotent stem cells (iPSCs), providing a rigorous context for drug screening and mechanistic studies. "Our aim is straightforward: to give them the right resources to set neuroscience in motion," said a spokesperson from Creative Biolabs.
These platforms are part of Creative Biolabs' broader commitment to advancing neuroscience research. For more information on their solutions, visit https://neuros.creative-biolabs.com/.
